Various studies examined the use of neutrophil gelatinase-associated lipocalin (NGAL) for the early diagnosis of AKI, demonstrating the accuracy and additional clinical benefits of this biomarker [4,5,6,7,8,9,10,11]. Here, LCN2 is linked to acute kidney injury.